Biggest News Aggregation in the World
📰 Dexcom News

Page 103 - Dexcom News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Dexcom. Real-time updates on events, politics, business and more.

DexCom (NASDAQ:DXCM) Price Target Increased to $160.00 by Analysts at Piper Sandler

DexCom (NASDAQ:DXCM – Free Report) had its price target lifted by Piper Sandler from $150.00 to $160.00 in a research note issued to investors on Friday morning, FlyOnTheWall reports. A number of other equities analysts have also commented on the company. Robert W. Baird raised their price target on DexCom from $145.00 to $153.00 in […]
United States Jeremem Sylvain Robertw Baird Piper Sandler Morgan Stanley First Horizon Advisors Inc

Nisa Investment Advisors LLC Has $6.94 Million Holdings in DexCom, Inc. (NASDAQ:DXCM)

Nisa Investment Advisors LLC increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 5.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 59,712 shares of the medical device company’s stock after purchasing an additional 2,993 shares during […]
United States Stifel Nicolaus Jeremem Sylvain Steven Robert Pacelli Exchange Commission Nisa Investment Advisors

Daiwa Securities Group Inc. Lowers Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)

Daiwa Securities Group Inc. lessened its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 4.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 49,637 shares of the medical device company’s stock after selling 2,526 shares during the period. Daiwa […]
United States Steven Robert Pacelli Dexcom Company Profile Parnassus Investments Associates Corp Morgan Stanley

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Mitsubishi UFJ Asset Management UK Ltd. Buys New Shares in DexCom, Inc. (NASDAQ:DXCM)

Mitsubishi UFJ Asset Management UK Ltd. purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 21,000 shares of the medical device company’s stock, valued at approximately […]
United Kingdom United States Jeremem Sylvain Steven Robert Pacelli Mitsubishi Ufj Morgan Stanley

FOXNEWS Gutfeld June 4, 2024 07:42:00

To your phone or dexcom receiver without painful receiver without painful fingerstic the arrow shows the direction your glucose is heading up downh or steady. >> and because dexcom g7 is the most accurate cge m can make id better decisions about food, medication and activity inthreei the moment. after using the dexcom g7, my onesieasy to e has never beee i lead linede dancing three tims a week and im just living a great life now. its s (femalo easy to use dexcn has given me confidencede has give...
Gettin G Dexcom G7 Cge M Painful Fingerstic The Arrow Activity Inthreei Me Confidencede

Banque Pictet & Cie SA Has $7.01 Million Holdings in DexCom, Inc. (NASDAQ:DXCM)

Banque Pictet & Cie SA lessened its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 35.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,305 shares of the medical device company’s stock after selling 33,789 shares during the quarter. […]
United States Steven Robert Pacelli Stifel Nicolaus Banque Pictet Cie Jeremem Sylvain Morgan Stanley

DexCom (NASDAQ:DXCM) Downgraded to "Hold" at StockNews.com

StockNews.com downgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a report issued on Thursday morning. A number of other analysts have also commented on DXCM. Barclays lifted their target price on shares of DexCom from $110.00 to $115.00 in a report on Monday, May 1st. Citigroup […]
United States Jacob Steven Leach Jeremem Sylvain Morgan Stanley Dexcom Inc Geode Capital Management

Insider Selling: DexCom, Inc. (NASDAQ:DXCM) Director Sells 5,031 Shares of Stock

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) Director Steven Robert Pacelli sold 5,031 shares of the company’s stock in a transaction that occurred on Friday, July 14th. The stock was sold at an average price of $136.00, for a total transaction of $684,216.00. Following the completion of the transaction, the director now owns 126,831 shares […]
United States Steven Robert Pacelli Raymond James Kb Financial Partners Dexcom Company Profile Whittier Trust Co
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science